This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Jae-Chul Lee: Innovator in Pharmaceutical Chemistry
Introduction
Jae-Chul Lee is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. His work is characterized by a focus on efficiency and purity in chemical synthesis.
Latest Patents
Jae-Chul Lee holds a patent for a method titled "Method for the preparation of D-erythro-2,2-difluoro-2-deoxy-1-oxoribose derivative." This innovative method allows for the easy and selective preparation of the 3R-carboxylate enantiomer derivative of formula (III). The process enables the efficient production of a highly pure D-erythro-2,2-difluoro-2-deoxy-1-oxoribose derivative from the compound of formula (III) as an intermediate. He has 1 patent to his name.
Career Highlights
Jae-Chul Lee is currently employed at Hanmi Pharm. Co., Ltd., a leading pharmaceutical company in South Korea. His role involves research and development, where he applies his expertise to create innovative solutions in drug formulation and synthesis.
Collaborations
Throughout his career, Jae-Chul Lee has collaborated with notable colleagues, including Jaeheon Lee and Gha-Seung Park. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Jae-Chul Lee's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in the field. His patent reflects a commitment to advancing drug development through efficient and selective methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile